The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index; 37 of the 64 sources its claims cite were checked for support.
Mitochondrial Dysfunction Contributes to Oncogene-Induced Senescence
Open accessAbstract
The expression of oncogenic ras in normal human cells quickly induces an aberrant proliferation response that later is curtailed by a cell cycle arrest known as cellular senescence. Here, we show that cells expressing oncogenic ras display an increase in the mitochondrial mass, the mitochondrial DNA, and the mitochondrial production of reactive oxygen species (ROS) prior to the senescent cell cycle arrest. By the time the cells entered senescence, dysfunctional mitochondria accumulated around the nucleus. The mitochondrial dysfunction was accompanied by oxidative DNA damage, a drop in ATP levels, and the activation of AMPK. The increase in mitochondrial mass and ROS in response to oncogenic ras depended on intact p53 and Rb tumor suppression pathways. In addition, direct interference with mitochondrial functions by inhibiting the expression of the Rieske iron sulfur protein of complex III or the use of pharmacological inhibitors of the electron transport chain and oxidative phosphorylation was sufficient to trigger senescence. Taking these results together, this work suggests that mitochondrial dysfunction is an effector pathway of oncogene-induced senescence.
Overview
CoChat Summary
TL;DR
Oncogenic Ras expression in normal human IMR90 fibroblasts increases mitochondrial mass, mtDNA, and mitochondrial ROS before senescence, then leads to depolarized perinuclear mitochondria, oxidative DNA damage, ATP loss, and AMPK activation. These mitochondrial changes require p53 or Rb, and direct mitochondrial interference by RISP knockdown or rotenone/oligomycin is sufficient to trigger senescence, suggesting mitochondrial dysfunction is an effector pathway of oncogene-induced senescence.
Key findings
- RasV12 induced mitochondrial superoxide by day 2 after selection and higher levels by day 8; mtDNA increased after day 2, and mitochondrial biogenesis genes NRF2a, PGC1α, PGC1β, and TFAM were induced before senescence, with NRF1 increased later.
- By senescence at day 8, Ras-expressing cells showed perinuclear depolarized mitochondria by JC-1, H2O2 accumulation, 8-OHdG oxidative DNA damage, SOD2/catalase induction by day 6, decreased ATP equivalent to oligomycin treatment, active AMPK, and higher glucose consumption than controls.
- p53 or Rb was required: shp53 alone or E7 alone did not prevent Ras-induced mitochondrial mass/ROS, E7 partially reduced them, and shp53 plus E7 prevented ROS, mitochondrial mass, and senescence; shp16 with shp53 also prevented these changes, and E1A inhibited Ras-dependent mitochondrial mass/ROS.
- Direct mitochondrial dysfunction triggered senescence: RISP knockdown caused growth arrest by 6 days with SA-β-Gal, G1 arrest, low BrdU, DNA damage foci, PML bodies, hypophosphorylated Rb, low Mcm6, p21/HDM2 induction, increased ROS/mtDNA, decreased ATP, and AMPK activation; rotenone and oligomycin inhibited growth, with rotenone more efficient at inducing SA-β-Gal, PML bodies, superoxide, and mitochondrial mass.
Methods
- Normal human diploid IMR90 fibroblasts were infected with retroviral Ha-RasV12 or controls, selected with puromycin, and analyzed at 2 days and 8 days after selection; additional experiments used shRNAs against p53, p16, or RISP, E7, E1A, rotenone, and oligomycin.
- Assays included qPCR for mtDNA/nuDNA and gene expression; FACS and immunofluorescence for MitoFluor Green, JC-1, MitoSox, DHE, DCFDA, BrdU/PI, SA-β-gal, 8-OHdG, γH2AX, PML, and catalase; Western blotting for AMPK, phospho-AMPK, ACC, p53, p21, HDM2, Ras, Rb, RISP, and tubulin; plus ATP and glucose-consumption measurements.
- Main analysis compared Ras-expressing versus control cells at pre-senescent and senescent time points, tested p53/Rb pathway requirements, and tested sufficiency of mitochondrial dysfunction via RISP knockdown and mitochondrial inhibitors.
Limitations
- Stated: the authors cannot eliminate possible contributions of increased cellular ATPase activities or metabolic futile cycles to the ATP drop; the identity and role of perinuclear vacuoles remain to be investigated; it remains challenging to determine whether superoxide production or loss of membrane potential comes first; more studies are required to link p53 and Rb to mitochondria during OIS; further studies are needed for tumor-selective mitochondrial strategies.
- Stated: antioxidant treatment retarded but did not completely prevent OIS (data not shown).
- Evident from the text: findings are largely in one normal human fibroblast line (IMR90) with retroviral RasV12, with no in vivo tumor model; several conclusions rely on pharmacological inhibitors and shRNA, and some supporting results are in supplemental figures or not shown.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
23 Valid · 1 Not valid · 13 Not checked · 95 Own results and interpretations
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“It has been demonstrated that mitochondria play a critical role in replicative senescence, and several mitochondrial changes, including an increase in the production of reactive oxygen species (ROS), were reported in cells with short telomeres (34, 35).”
What the sources say
- Supportedcites [34] source
The Introduction links short telomere length with mitochondrial dysfunction in senescent-phenotype fibroblasts. The Results section “Mitochondrial Dysfunction in Senescent Fibroblasts” reports increased mitochondrial superoxide and other mitochondrial changes, including reduced membrane potential and increased mitochondrial mass. No page numbers are available in our copy. (LLM, conf=0.89)
- Not checked — no full text of the sourcecites [35] source
boostedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“OIS is phenotypically similar to the senescence response triggered by short telomeres, also known as replicative senescence (6).”
What the sources say
- Supportedcites [6] source
The paper describes dysfunctional telomeres and overexpressed oncogenes as distinct triggers of the same cellular senescence response (Abstract; Good Citizens—Cells Senesce in Response to Potential Cancer-Causing Events, page unavailable). It also identifies telomere-shortening-induced arrest as replicative senescence. This supports the broad claim of phenotypic similarity, though the passages do not compare individual phenotypic features. (LLM, conf=0.88)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“In turn, the loss of membrane potential may increase ROS production (4).”
What the sources say
- Partly supportedcites [4] sourceExperimental — accuracy not yet measured
The Abstract (page unavailable) reports that PTP opening, which uncouples mitochondria, increased H₂O₂ production when NADH was supplied. It also reports that PTP opening inhibited H₂O₂ production without that supply, while uncoupling has been shown to decrease ROS. The paper attributes the increase to a change in complex I, not to loss of membrane potential itself. (LLM, conf=0.85)
hedgedstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“It has been demonstrated that mitochondria play a critical role in replicative senescence, and several mitochondrial changes, including an increase in the production of reactive oxygen species (ROS), were reported in cells with short telomeres (34, 35).”
What the sources say
- Supportedcites [34] source
The Introduction reports that reducing mitochondrial superoxide generation delayed telomere damage and extended replicative lifespan. The Discussion concludes that mitochondrial ROS production is a determinant of telomere-dependent replicative senescence. (LLM, conf=0.94)
- Not checked — no full text of the sourcecites [35] source
boostedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“OIS also involves the DNA damage response (2, 15, 28), but the mechanism of DNA damage and the contribution of mitochondria to it are unclear.”
What the sources say
- Not checked — no full text of the sourcecites [2] source
- Not checked — no full text of the sourcecites [15] source
- Supportedcites [28] source
The section “STAT5A and RasV12 induce a constitutive activation of the DNA damage signaling pathway” reports DNA damage foci in cells induced to senesce by either oncogene. The “ODDI persist in cells that bypassed senescence” section also concludes that oncogenic activity activates the DNA damage signaling pathway, which supports the attributed claim. (LLM, conf=0.94)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
70 more claims · 4 with their cited sources checked
Create a free account to see all 132 claims and every source verdict.
- Probably not a substantial claim. 24
- It may state two separate claims as one. 38
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“sustained activation of 5′AMP-activated protein kinase (AMPK), a major bioenergetic sensor, is a hallmark of senescence (Moiseeva et al., 2009) and can induce a senescence arrest”
From Mitochondrial Dysfunction Induces Senescence with a Distinct Secretory Phenotype (2016) · cites this paper as Moiseeva et al., 2009
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“ROS can damage DNA directly or through oxidative lesions that increase replication fork collapse by preventing its progression, thereby exacerbating the formation of DNA breaks and DDR activation [121,122].”
From Mechanisms and Regulation of Cellular Senescence (2021) · cites this paper as [121]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In the early stage of senescence, mitochondria do not function properly and display impaired oxidative phosphorylation capacity and reduced inner membrane potential, resulting in ROS overproduction [120,121,208,211].”
From Mechanisms and Regulation of Cellular Senescence (2021) · cites this paper as [121]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Dysfunctional mitochondria can induce cellular senescence in culture (Moiseeva et al., 2009; Wang et al., 2003) and in vivo (Dai et al., 2010; Kang et al., 2013).”
From Mitochondrial Dysfunction Induces Senescence with a Distinct Secretory Phenotype (2016) · cites this paper as Moiseeva et al., 2009
The cited source says what the claim attributes to it.
In the citing paper
“Mitochondrial ROS can damage nuclear DNA, thus activating a DNA damage response that induces senescence (Moiseeva et al., 2009; Passos et al., 2010).”
From Mitochondrial Dysfunction Induces Senescence with a Distinct Secretory Phenotype (2016) · cites this paper as Moiseeva et al., 2009
Citations
Cites
Hengartner, M. O. (2000) · Nature · doi:10.1038/35037710 · Cited by 5,779
Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a
Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D., & Lowe, S. W. (1997) · Cell · doi:10.1016/s0092-8674(00)81902-9 · Cited by 5,218 · cited 8×
“Ras-induced senescence in human cells can be mediated by either the p53 or the Rb family of tumor suppressors (28, 29, 43, 48).”
BackgroundInfluentialA DNA damage checkpoint response in telomere-initiated senescence
Fagagna, F. D. D., Reaper, P. M., Clay-Farrace, L., Fiegler, H., Carr, P., von Zglinicki, T., Saretzki, G., Carter, N. P., & Jackson, S. P. (2003) · Nature · doi:10.1038/nature02118 · Cited by 2,917 · cited 1×
“Replicative senescence is, in essence, the consequence of a DNA damage response triggered by short telomeres (11).”
BackgroundDNA damage response as a candidate anti-cancer barrier in early human tumorigenesis
Bartkova, J., Hořejší, Z., Koed, K., Krämer, A., Tort, F., Zieger, K., Guldberg, P., Sehested, M., Nesland, J. M., Lukas, C., et al. (2005) · Nature · doi:10.1038/nature03482 · Cited by 2,688
A model for p53-induced apoptosis
Polyak, K., Xia, Y., Zweier, J. L., Kinzler, K. W., & Vogelstein, B. (1997) · Nature · doi:10.1038/38525 · Cited by 2,500
Senescent cells, tumor suppression, and organismal aging: good citizens, bad neighbors
Campisi, J. (2005) · Cell · doi:10.1016/j.cell.2005.02.003 · Cited by 2,379
Rb-mediated heterochromatin formation and silencing of E2F target genes during cellular senescence
Narita, M., Nuñez, S., Heard, E., Narita, M., Lin, A. W., Hearn, S. A., Spector, D. L., Hannon, G. J., & Lowe, S. W. (2003) · Cell · doi:10.1016/s0092-8674(03)00401-x · Cited by 2,278 · cited 1×
“Thus, we used an shRNA against p16INK4 (32) alone or in combination with shp53 to evaluate the roles of the p16/Rb and p53 pathways in the mitochondrial changes induced by oncogenic ras.”
MethodActivation of the DNA damage checkpoint and genomic instability in human precancerous lesions
Gorgoulis, V. G., Vassiliou, L.-V. F., Karakaidos, P., Zacharatos, P., Kotsinas, A., Liloglou, T., Venere, M., DiTullio, R. A., Kastrinakis, N. G., Levy, B., et al. (2005) · Nature · doi:10.1038/nature03485 · Cited by 2,009
Mitochondria: Dynamic Organelles in Disease, Aging, and Development
Chan, D. C. (2006) · Cell · doi:10.1016/j.cell.2006.06.010 · Cited by 1,987
Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints
Bartkova, J., Rezaei, N., Liontos, M., Karakaidos, P., Kletsas, D., Issaeva, N., Vassiliou, L.-V. F., Kolettas, E., Niforou, K., Zoumpourlis, V. C., et al. (2006) · Nature · doi:10.1038/nature05268 · Cited by 1,986 · cited 1×
“In particular, E1A inhibits p53 phosphorylation at serine 15 (14), a hallmark of the activation of the DNA damage response during senescence (3, 12).”
Background
Cited by
Cellular Senescence: Defining a Path Forward
Gorgoulis, V., Adams, P. D., Alimonti, A., Bennett, D. C., Bischof, O., Bishop, C., Campisi, J., Collado, M., Evangelou, K., Ferbeyre, G., et al. (2019) · Cell · doi:10.1016/j.cell.2019.10.005 · Cited by 3,225
Self-citationThe essence of senescence: Figure 1.
Kuilman, T., Michaloglou, C., Mooi, W. J., & Peeper, D. S. (2010) · Genes & Development · doi:10.1101/gad.1971610 · Cited by 2,038
“It is widely assumed that not oxygen itself, but rather ROS produced by mitochondria are involved in senescence (Lu and Finkel 2008; Moiseeva et al. 2009).”
BackgroundMitochondrial Dysfunction Induces Senescence with a Distinct Secretory Phenotype
Wiley, C. D., Velarde, M. C., Lecot, P., Liu, S., Sarnoski, E. A., Freund, A., Shirakawa, K., Lim, H. W., Davis, S. S., Ramanathan, A., et al. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2015.11.011 · Cited by 1,275
“Dysfunctional mitochondria can induce cellular senescence in culture (Moiseeva et al., 2009; Wang et al., 2003) and in vivo (Dai et al.”
BackgroundInfluentialCellular Senescence: Aging, Cancer, and Injury
Calcinotto, A., Kohli, J., Zagato, E., Pellegrini, L., Demaria, M., & Alimonti, A. (2019) · Physiological Reviews · doi:10.1152/physrev.00020.2018 · Cited by 1,270
“IFN can also induce senescence by triggering DNA damage in the target cells (232, 312).”
BackgroundMitochondrial dysfunction in cell senescence and aging
Miwa, S., Kashyap, S., Chini, E., & von Zglinicki, T. (2022) · Journal of Clinical Investigation · doi:10.1172/jci158447 · Cited by 1,061
“The same type of mitochondrial dysfunction was also found in oncogene- (RAS-)induced senescence (69).”
BackgroundFeedback between p21 and reactive oxygen production is necessary for cell senescence
Passos, J. F., Nelson, G., Wang, C., Richter, T., Simillion, C., Proctor, C. J., Miwa, S., Olijslagers, S., Hallinan, J., Wipat, A., et al. (2010) · Molecular Systems Biology · doi:10.1038/msb.2010.5 · Cited by 1,019
“A DNA damage response (DDR), triggered by uncapped telomeres or non-telomeric DNA damage, is the most prominent initiator of senescence (d’Adda di Fagagna, 2008).”
Exploiting senescence for the treatment of cancer
Wang, L., Lankhorst, L., & Bernards, R. (2022) · Nature Reviews Cancer · doi:10.1038/s41568-022-00450-9 · Cited by 867
Cellular senescence and its effector programs
Salama, R., Sadaie, M., Hoare, M., & Narita, M. (2014) · Genes & Development · doi:10.1101/gad.235184.113 · Cited by 855
“Although, the Peeper and Gottlieb groups (Kaplon et al. 2013) did not report the actual levels of ATP production in OIS cells, another recent study by Dörr et al. (2013) has shown an increase of ATP production in both TIS lymphomas and OIS HDFs.”
BackgroundInfluentialSenescence and aging: the critical roles of p53
Rufini, A., Tucci, P., Celardo, I., & Melino, G. (2013) · Oncogene · doi:10.1038/onc.2012.640 · Cited by 798
Mitochondria are required for pro-ageing features of the senescent phenotype
Correia‐Melo, C., Marques, F. D., Anderson, R., Hewitt, G., Hewitt, R., Cole, J., Carroll, B. M., Miwa, S., Birch, J., Merz, A., et al. (2016) · The EMBO Journal · doi:10.15252/embj.201592862 · Cited by 796
“Chemical and genetic interventions impacting on the mitochondrial electron transport chain have been shown to enhance OIS (Moiseeva et al , 2009); however, to date, no study has effectively evaluated the necessity of mitochondria for the induction of the senescent phenotype.”
InfluentialKRAS: feeding pancreatic cancer proliferation
Bryant, K. L., Mancias, J. D., Kimmelman, A. C., & Der, C. J. (2014) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2013.12.004 · Cited by 675
“They showed that a distinct type of autophagy, mitophagy, appears to play an important role in improving the survival of these cells by removing damaged mitochondria, which otherwise would contribute to increased intracellular ROS levels [63].”
Moiseeva, O., Deschênes‐Simard, X., St‐Germain, E., Igelmann, S., Huot, G., Cadar, A. E., Bourdeau, V., Pollak, M. N., & Ferbeyre, G. (2013) · Aging Cell · doi:10.1111/acel.12075 · Cited by 654
“Infection and senescence protocols were described in (Moiseeva et al., 2009).”
MethodSelf-citationJurk, D., Wang, C., Miwa, S., Maddick, M., Korolchuk, V., Tsolou, A., Gonos, E. S., Thrasivoulou, C., Jill Saffrey, M., Cameron, K., et al. (2012) · Aging Cell · doi:10.1111/j.1474-9726.2012.00870.x · Cited by 598
“…Tyne NE4 5PL, UK 2Department of Life Sciences, The Open University, Milton Keynes MK7 6AA, UK 3National Hellenic Research Foundation, Institute of Biological Research and Biotechnology, Athens, Greece 4Department of Anatomy and Developmental Biology, University College London, London WC1E 6DE, UK”
BackgroundPrigione, A., Fauler, B., Lurz, R., Lehrach, H., & Adjaye, J. (2010) · Stem Cells · doi:10.1002/stem.404 · Cited by 598
Rejuvenating senescent and centenarian human cells by reprogramming through the pluripotent state
Lapasset, L., Milhavet, O., Prieur, A., Besnard, E., Babled, A., Aït-Hamou, N., Leschik, J., Pellestor, F., Ramirez, J.-M., De Vos, J., et al. (2011) · Genes & Development · doi:10.1101/gad.173922.111 · Cited by 570
“As previously shown, the red/green ratio decreases in fibroblasts with senescence and aging (Fig. 3D; Passos et al. 2007;Moiseeva et al. 2009).”
BackgroundRabinovitch, R. C., Samborska, B., Faubert, B., Ma, E. H., Gravel, S.-P., Andrzejewski, S., Raissi, T. C., Pause, A., St.-Pierre, J., & Jones, R. G. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.09.026 · Cited by 543
“RISP knockdown increased phosphorylation of both AMPK, as shown previously (Moiseeva et al., 2009), and the downstream effectors ULK1 and ACC in unstressed cells (Figure 1D).”
Choosing between glycolysis and oxidative phosphorylation: a tumor’s dilemma?
Jose, C., Bellance, N., & Rossignol, R. (2011) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2010.10.012 · Cited by 518
“showed that cells expressing oncogenic RAS display an increase in mitochondrial mass, mitochondrial DNA, and mitochondrial production of reactive oxygen species (ROS) prior to the senescent cell cycle arrest [25].”
BackgroundCancer as a metabolic disease: implications for novel therapeutics
Seyfried, T. N., Flores, R. E., Poff, A. M., & D'Agostino, D. P. (2014) · Carcinogenesis · doi:10.1093/carcin/bgt480 · Cited by 472
“As MYC and HIF-1 drive glycolysis, their upregulation would be necessary to prevent senescence following respiratory impairment (18,158).”
BackgroundInside and out: the activities of senescence in cancer
Pérez-Mancera, P. A., Young, A. R. J., & Narita, M. (2014) · Nature Reviews Cancer · doi:10.1038/nrc3773 · Cited by 462
mTOR as a central regulator of lifespan and aging
Papadopoli, D., Boulay, K., Kazak, L., Pollak, M., Mallette, F., Topisirovic, I., & Hulea, L. (2019) · F1000Research · doi:10.12688/f1000research.17196.1 · Cited by 440
Mitochondria in Cell Senescence: Is Mitophagy the Weakest Link?
Korolchuk, V. I., Miwa, S., Carroll, B., & von Zglinicki, T. (2017) · EBioMedicine · doi:10.1016/j.ebiom.2017.03.020 · Cited by 409
Mechanisms and Regulation of Cellular Senescence
Roger, L., Tomas, F., & Gire, V. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222313173 · Cited by 395
“In the early stage of senescence, mitochondria do not function properly and display impaired oxidative phosphorylation capacity and reduced inner membrane potential, resulting in ROS overproduction [120,121,208,211].”
BackgroundAxis of ageing: telomeres, p53 and mitochondria
Sahin, E., & DePinho, R. A. (2012) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3352 · Cited by 345
Lacroix, M., Riscal, R., Arena, G., Linares, L. K., & Le Cam, L. (2020) · Molecular Metabolism · doi:10.1016/j.molmet.2019.10.002 · Cited by 373
Metformin reduces endogenous reactive oxygen species and associated DNA damage
Algire, C., Moiseeva, O., Deschênes-Simard, X., Amrein, L., Petruccelli, L., Birman, E., Viollet, B., Ferbeyre, G., & Pollak, M. N. (2012) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-11-0536 · Cited by 372
“The ability of metformin to reduce ROS accumulation in these cells is consistent with an effect of reducing ROS formation rather than increasing ROS detoxifying mechanisms, which were previously found to be insufficient to cope with the amounts of ROS produced in Ras-expressing cells (34).”
BackgroundSelf-citationVizioli, M. G., Liu, T., Miller, K. N., Robertson, N. A., Gilroy, K., Lagnado, A. B., Perez-Garcia, A., Kiourtis, C., Dasgupta, N., Lei, X., et al. (2020) · Genes & Development · doi:10.1101/gad.331272.119 · Cited by 359
“Senescentcellsaremetabolicallyactivebutaccumu-latedysfunctionalmitochondriaresultinginincreased mitochondrialmass,increasedoxygenconsumption,de-creasedefficiencyofoxidativephosphorylation,decreased membranepotential,andincreasedlevelsofreactive oxygenspecies(ROS)(Passosetal.2007;Moiseevaetal.”
Höhn, A., Weber, D., Jung, T., Ott, C., Hugo, M., Kochlik, B., Kehm, R., König, J., Grune, T., & Castro, J. P. (2017) · Redox Biology · doi:10.1016/j.redox.2016.12.001 · Cited by 366
“This educational review and the accompanying illustrations are aimed to provide an introduction to the field of aging focusing on the above mentions hallmarks.”
BackgroundMitochondrial effectors of cellular senescence: beyond the free radical theory of aging
Ziegler, D. V., Wiley, C. D., & Velarde, M. C. (2015) · Aging Cell · doi:10.1111/acel.12287 · Cited by 354
“of ROS is associated with the implementation of replicative senescence, oncogene-induced senescence, and p16-induced senescence (Colavitti & Finkel, 2005; Passos et al., 2007, 2010; Lu & Finkel, 2008; Moiseeva et al., 2009; Imai et al., 2014).”
BackgroundInfluentialMitochondrial fusion supports increased oxidative phosphorylation during cell proliferation
Yao, C.-H., Wang, R., Wang, Y., Kung, C.-P., Weber, J. D., & Patti, G. J. (2019) · eLife · doi:10.7554/elife.41351 · Cited by 337
“Proliferating fibroblasts increase their consumption rate of cystine by two-fold without altering the expression level of the cystine/glutamate antiporter SLC7A11.”
InfluentialMitochondrial dysfunction in aging
Guo, Y., Guan, T., Shafiq, K., Yu, Q., Jiao, X., Na, D., Li, M., Zhang, G., & Kong, J. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2023.101955 · Cited by 339
Cellular senescence: all roads lead to mitochondria
Martini, H., & Passos, J. F. (2023) · The FEBS Journal · doi:10.1111/febs.16361 · Cited by 334
Ralph, S. J., Rodríguez-Enríquez, S., Neuzil, J., Saavedra, E., & Moreno-Sánchez, R. (2010) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2010.02.008 · Cited by 331
Mitochondrial dysfunction and cell senescence: deciphering a complex relationship
Chapman, J., Fielder, E., & Passos, J. F. (2019) · FEBS Letters · doi:10.1002/1873-3468.13498 · Cited by 325
Pluquet, O., Pourtier, A., & Abbadie, C. (2015) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00334.2014 · Cited by 305
“It occurs in SIPS, OIS, and OIIS and can also act as a supernumerary mechanism in parallel to telomere shortening during replicative senescence (70, 80, 119).”
BackgroundInterplay between oxidant species and energy metabolism
Quijano, C., Trujillo, M., Castro, L., & Trostchansky, A. (2016) · Redox Biology · doi:10.1016/j.redox.2015.11.010 · Cited by 304
“Both NADPH oxidases (Nox1 and Nox4) [81,82] and mitochondria [83] have been postulated as plausible sources of oxidants in oncogenic Ras-induced senescence.”
BackgroundVelarde, M. C., Flynn, J. M., Day, N. U., Melov, S., & Campisi, J. (2012) · Aging · doi:10.18632/aging.100423 · Cited by 299
“Because mitochondrial dysfunction is implicated as both a cause and consequence of senescence [10-17] we stained skin sections from young, middle-aged and old mice for succinate dehydrogenase (SDH), a measure of mitochondrial electron transport chain complex II activity.”
BackgroundAging of the cells: Insight into cellular senescence and detection Methods.
Mohamad Kamal, N. S., Safuan, S., Shamsuddin, S., & Foroozandeh, P. (2020) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2020.151108 · Cited by 287
Lagoumtzi, S. M., & Chondrogianni, N. (2021) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2021.05.003 · Cited by 279
Kishton, R. J., Barnes, C. E., Nichols, A. G., Cohen, S., Gerriets, V. A., Siska, P. J., Macintyre, A. N., Goraksha-Hicks, P., de Cubas, A. A., Liu, T., et al. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.03.008 · Cited by 260
“While our findings here are limited to Notch-induced TALL, Ras and Myc can also each drive metabolic stress in tumor cells (Liu et al., 2012; Moiseeva et al., 2009).”
BackgroundOncogene-induced senescence: the bright and dark side of the response
Gorgoulis, V. G., & Halazonetis, T. D. (2010) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2010.07.013 · Cited by 257
Physiological and pathological consequences of cellular senescence
Burton, D. G. A., & Krizhanovsky, V. (2014) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-014-1691-3 · Cited by 253
“Although initially limited to in vitro studies, numerous findings suggest that OIS might be mediated, at least partially, by the induction of DNA damage, often associated with elevated reactive oxygen species (ROS) levels [10–14].”
BackgroundMitochondrial Homeostasis and Cellular Senescence
Vasileiou, P., Evangelou, K., Vlasis, K., Fildisis, G., Panayiotidis, M., Chronopoulos, E., Passias, P.-G., Kouloukoussa, M., Gorgoulis, V., & Havaki, S. (2019) · Cells · doi:10.3390/cells8070686 · Cited by 244
“Of note, newly formed mitochondria in Ras-senescent cells were dysfunctional, with compromised ATP generation and increased ROS, due to the continuous oncogenic stress [162].”
BackgroundSeok, J., Jung, H. S., Park, S., Lee, J. O., Kim, C. J., & Kim, G. J. (2020) · Stem Cell Research & Therapy · doi:10.1186/s13287-019-1471-y · Cited by 236
Fibronectin in Cancer: Friend or Foe
Lin, T.-C., Yang, C.-H., Cheng, L.-H., Chang, W.-T., Lin, Y.-R., & Cheng, H.-C. (2019) · Cells · doi:10.3390/cells9010027 · Cited by 234
“In the beginning of oncogenic processes, pro-inflammatory cytokines in non-autonomous SASP [113,161], produced and secreted by the senescent parenchymal cells that suffer diversity of stresses, are essentially responsible for the alteration of surrounding microenvironments, including fibroblast activities [162,163].”
BackgroundWiel, C., Lallet-Daher, H., Gitenay, D., Gras, B., Le Calvé, B., Augert, A., Ferrand, M., Prevarskaya, N., Simonnet, H., Vindrieux, D., et al. (2014) · Nature Communications · doi:10.1038/ncomms4792 · Cited by 231
Mitochondria in the signaling pathways that control longevity and health span
Akbari, M., Kirkwood, T. B. L., & Bohr, V. A. (2019) · Ageing Research Reviews · doi:10.1016/j.arr.2019.100940 · Cited by 230
“Cells treated with various DDR activators and senescence inducers display increased mitochondrial mass prior to senescent cell cycle arrest (Moiseeva et al., 2009).”
Gilad, O., Nabet, B. Y., Ragland, R. L., Schoppy, D. W., Smith, K. D., Durham, A. C., & Brown, E. J. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-2286 · Cited by 228
Iske, J., Seyda, M., Heinbokel, T., Maenosono, R., Minami, K., Nian, Y., Quante, M., Falk, C. S., Azuma, H., Martin, F., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-18039-x · Cited by 211
Feng, Y., Santoriello, C., Mione, M., Hurlstone, A., & Martin, P. (2010) · PLoS Biology · doi:10.1371/journal.pbio.1000562 · Cited by 206
“It has previously been shown that oncogenic RAS-transformed cells suffer ROS stress [65], but what is not clear is how individual malignant cells disrupt tissue homeostasis in order to trigger otherwise healthy, epithelial neighbors to do likewise.”
BackgroundCellular Senescence in Postmitotic Cells: Beyond Growth Arrest
Sapieha, P., & Mallette, F. A. (2018) · Trends in Cell Biology · doi:10.1016/j.tcb.2018.03.003 · Cited by 193
Telomeres, oxidative stress and inflammatory factors: partners in cellular senescence?
Correia-Melo, C., Hewitt, G., & Passos, J. F. (2014) · Longevity & Healthspan · doi:10.1186/2046-2395-3-1 · Cited by 194
“Mitochondrial dysfunction resulted in the loss of ATP and activation of AMPK; in addition, mitochondrial-derived ROS were shown to contribute to the oxidation of DNA [66].”
BackgroundTumor suppressor activity of the ERK/MAPK pathway by promoting selective protein degradation
Deschênes-Simard, X., Gaumont-Leclerc, M.-F., Bourdeau, V., Lessard, F., Moiseeva, O., Forest, V., Igelmann, S., Mallette, F. A., Saba-El-Leil, M. K., Meloche, S., et al. (2013) · Genes & Development · doi:10.1101/gad.203984.112 · Cited by 194
Self-citationRegulation of E2Fs and senescence by PML nuclear bodies
Vernier, M., Bourdeau, V., Gaumont-Leclerc, M.-F., Moiseeva, O., Bégin, V., Saad, F., Mes-Masson, A.-M., & Ferbeyre, G. (2011) · Genes & Development · doi:10.1101/gad.1975111 · Cited by 177
Self-citationLai, P., Liu, L., Bancaro, N., Troiani, M., Calì, B., Li, Y., Chen, J., Singh, P. K., Arzola, R. A., Attanasio, G., et al. (2025) · Immunity · doi:10.1016/j.immuni.2025.03.005 · Cited by 174
Similarities and interplay between senescent cells and macrophages
Behmoaras, J., & Gil, J. (2021) · Journal of Cell Biology · doi:10.1083/jcb.202010162 · Cited by 158
“focus of increasing reports studying the immune and metabolic interplay in macrophage effector functions (Mart́ınez-Reyes and Chandel, 2020) and during senescence (Kaplon et al., 2013; LópezOt́ın et al., 2013; Moiseeva et al., 2009).”
BackgroundFrasca, D., Diaz, A., Romero, M., & Blomberg, B. B. (2017) · Experimental Gerontology · doi:10.1016/j.exger.2016.12.001 · Cited by 160
Fibroblast senescence in the pathology of idiopathic pulmonary fibrosis
Waters, D. W., Blokland, K. E. C., Pathinayake, P. S., Burgess, J. K., Mutsaers, S. E., Prele, C. M., Schuliga, M., Grainge, C. L., & Knight, D. A. (2018) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00037.2018 · Cited by 163
Mitochondria: Are they causal players in cellular senescence?
Correia-Melo, C., & Passos, J. F. (2015) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2015.05.017 · Cited by 160
Oncogene-induced senescence results in marked metabolic and bioenergetic alterations
Quijano, C., Cao, L., Fergusson, M. M., Romero, H., Liu, J., Gutkind, S., Rovira, I. I., Mohney, R. P., Karoly, E. D., & Finkel, T. (2012) · Cell Cycle · doi:10.4161/cc.19800 · Cited by 155
Insulin‐like growth factor‐1 regulates the SIRT 1‐p53 pathway in cellular senescence
Tran, D., Bergholz, J., Zhang, H., He, H., Wang, Y., Zhang, Y., Li, Q., Kirkland, J. L., & Xiao, Z. (2014) · Aging Cell · doi:10.1111/acel.12219 · Cited by 161
“Notably, oncogene-induced premature senescence can also invoke ROS, leading to activation of p53 (Moiseeva et al., 2009).”
BackgroundCellular Senescence: From Mechanisms to Current Biomarkers and Senotherapies
Lucas, V., Cavadas, C., & Aveleira, C. A. (2023) · Pharmacological Reviews · doi:10.1124/pharmrev.122.000622 · Cited by 160
Tumour Cell Secretome in Chemoresistance and Tumour Recurrence
Madden, E. C., Gorman, A. M., Logue, S. E., & Samali, A. (2020) · Trends in Cancer · doi:10.1016/j.trecan.2020.02.020 · Cited by 159
Cell Senescence, DNA Damage, and Metabolism
Shmulevich, R., & Krizhanovsky, V. (2021) · Antioxidants & Redox Signaling · doi:10.1089/ars.2020.8043 · Cited by 157
“The glycolysis is elevated in senescence as a result of various triggers, including oncogene-induced senescence (59), genotoxic stress-induced senescence, and replicative senescence (22, 37, 53, 85).”
Mitochondrial – Endoplasmic reticulum interactions in the trophoblast: Stress and senescence
Burton, G. J., Yung, H. W., & Murray, A. J. (2016) · Placenta · doi:10.1016/j.placenta.2016.04.001 · Cited by 164
Mitochondrial Dysfunction and Ovarian Aging
Kasapoğlu, I., & Seli, E. U. (2020) · Endocrinology · doi:10.1210/endocr/bqaa001 · Cited by 168
Semiconducting Polymer Nanoreporters for Near‐Infrared Chemiluminescence Imaging of Immunoactivation
Cui, D. M., Li, J., Zhao, X., Pu, K., & Zhang, R. (2019) · Advanced Materials · doi:10.1002/adma.201906314 · Cited by 155
Lu, W., Hu, Y., Chen, G., Chen, Z., Zhang, H., Wang, F., Feng, L., Pelicano, H., Wang, H., Keating, M. J., et al. (2012) · PLoS Biology · doi:10.1371/journal.pbio.1001326 · Cited by 160
Cellular Senescence as the Causal Nexus of Aging
Bhatia‐Dey, N., Kanherkar, R. R., Stair, S. E., Makarev, E., & Csoka, A. B. (2016) · Frontiers in Genetics · doi:10.3389/fgene.2016.00013 · Cited by 168
“Most primary cell types are prone to senescence in response to oxidative stress caused by reactive oxygen species (ROS) primarily through telomere attrition (von Zglinicki, 2002), or oncogene activation (Moiseeva et al., 2009).”
BackgroundSummer, R. S., Shaghaghi, H., Schriner, D., Roque, W., Sales, D., Cuevas-Mora, K., Desai, V. S., Bhushan, A., Ramirez, M. I., & Romero, F. (2019) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00244.2018 · Cited by 157
“Cellular senescence of the lung epithelium has emerged as an important contributor to aging of the respiratory system and to the development of various respiratory diseases (16, 25, 47).”
BackgroundVercesi, A. E., Castilho, R. F., Kowaltowski, A. J., Oliveira, H. C. F., de Souza-Pinto, N. C., Figueira, T. R., & Busanello, E. N. B. (2018) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2018.08.034 · Cited by 152
Lang, A., Grether‐Beck, S., Singh, M., Kuck, F., Jakob, S., Kefalas, A., Altinoluk-Hambüchen, S., Graffmann, N., Schneider, M., Lindecke, A., et al. (2016) · Aging · doi:10.18632/aging.100905 · Cited by 146
SARS-CoV-2 Mediated Endothelial Dysfunction: The Potential Role of Chronic Oxidative Stress
Chang, R. P., Mamun, A., Dominic, A., & Le, N. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2020.605908 · Cited by 146
“Notably, the p53 transcription factor, which can initiate cell cycle arrest and senescence, can also reduce expression of manganese superoxide dismutase, thus perpetuating oxidative stress and subsequent senescence (Moiseeva et al., 2009; Passos et al., 2010).”
BackgroundRai, P., Young, J. J., Burton, D. G. A., Giribaldi, M. G., Önder, T. T., & Weinberg, R. A. (2010) · Oncogene · doi:10.1038/onc.2010.520 · Cited by 141
“This would suggest that such cells may be compensating for high levels of RAS oncoprotein signaling by increasing MTH1 levels to enhance detoxification of an oxidative lesion that contributes to the DDR and senescence induction (Moiseeva et al., 2009; Rai et al., 2009).”
BackgroundSenescent glia link mitochondrial dysfunction and lipid accumulation
Byrns, C. N., Perlegos, A. E., Miller, K. N., Jin, Z., Carranza, F. R., Manchandra, P., Beveridge, C. H., Randolph, C. E., Chaluvadi, V. S., Zhang, S., et al. (2024) · Nature · doi:10.1038/s41586-024-07516-8 · Cited by 160
Zhang, F., Lau, S. S., & Monks, T. J. (2010) · Toxicological Sciences · doi:10.1093/toxsci/kfq364 · Cited by 139
“The cationic dye JC-1 localizes to normal mitochondrial membranes as red aggregates and turns into a green monomer upon membrane depolarization (Moiseeva et al., 2009).”
BackgroundThe DNA Damage Response in Neurons: Die by Apoptosis or Survive in a Senescence-Like State?
Fielder, E., von Zglinicki, T., & Jurk, D. (2017) · Journal of Alzheimer's Disease · doi:10.3233/jad-161221 · Cited by 126
“This is dependent on signaling independently through both p53 and pRb and is accompanied with a collapse in mitochondrial membrane potential and an increased ROS production [188].”
The role of Stat5 transcription factors as tumor suppressors or oncogenes
Ferbeyre, G., & Moriggl, R. (2010) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2010.10.004 · Cited by 143
“The mechanism by which Stat5 induces DNA damage is not well understood, but as reported for oncogenic ras [160], Stat5 can induce changes in mitochondrial functions leading to the production of reactive oxygen species (ROS) and DNA damage [158,161].”
BackgroundSelf-citationLearning from oncocytic tumors: Why choose inefficient mitochondria?
Gasparre, G., Romeo, G. C., Rugolo, M., & Porcelli, A. M. (2010) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2010.08.006 · Cited by 129
mTOR Signaling from Cellular Senescence to Organismal Aging
Xu, S. (2014) · Aging and Disease · doi:10.14336/ad.2014.0500263 · Cited by 139
“Mitochondria dysfunction has been suggested to be an important mechanism leading to cellular senescence, as decreased mitochondrial function, impaired ATP generation and increased reactive oxygen species (ROS) levels are implicated in cellular senescence [62, 63].”
Src redox regulation: Again in the front line
Giannoni, E., Taddei, M. L., & Chiarugi, P. (2010) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2010.04.025 · Cited by 125
Marzia Perluigi, A., Domenico, F. D., Barone, E., & Butterfield, D. A. (2021) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2021.04.025 · Cited by 134
Extracellular Vesicles from Fibroblasts Induce Epithelial-Cell Senescence in Pulmonary Fibrosis
Kadota, T., Yoshioka, Y., Fujita, Y., Araya, J., Minagawa, S., Hara, H., Miyamoto, A., Suzuki, S., Fujimori, S., Kohno, T., et al. (2020) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2020-0002oc · Cited by 130
Oncogene-induced senescence: From biology to therapy
Zhu, H., Blake, S., Kusuma, F. K., Pearson, R. B., Kang, J., & Chan, K. T. (2020) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2020.111229 · Cited by 116
Oxidative Stress, Mitochondrial Dysfunction and the Mitochondria Theory of Aging
Kong, Y., Trabucco, S. E., & Zhang, H. (2014) · Interdisciplinary topics in gerontology and geriatrics · doi:10.1159/000358901 · Cited by 128
Leidal, A. M., Cyr, D. P., Hill, R. J., Lee, P. W. K., & McCormick, C. (2012) · Cell Host & Microbe · doi:10.1016/j.chom.2012.01.005 · Cited by 113
“AMPK activity has previously been implicated in OIS (Moiseeva et al., 2009), but the effects of AMPK on autophagy in OIS remain unexplored to date.”
BackgroundBose, R., Moors, M., Tofighi, R., Cascante, A., Hermanson, O., & Ceccatelli, S. (2010) · Cell Death and Disease · doi:10.1038/cddis.2010.60 · Cited by 113
Expansion and Cell-Cycle Arrest: Common Denominators of Cellular Senescence
Ogrodnik, M., Salmonowicz, H., Jurk, D., & Passos, J. F. (2019) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2019.06.011 · Cited by 104
Mitofusin 1 is required for female fertility and to maintain ovarian follicular reserve
Zhang, M., Bener, M. B., Jiang, Z., Wang, T., Esencan, E., Scott, R., Horváth, T. L., & Seli, E. U. (2019) · Cell Death and Disease · doi:10.1038/s41419-019-1799-3 · Cited by 111
Mitochondrial dysfunction and ovarian aging
Wang, T., Zhang, M., Jiang, Z., & Seli, E. U. (2017) · American Journal of Reproductive Immunology · doi:10.1111/aji.12651 · Cited by 116
Impaired OXPHOS Complex III in Breast Cancer
Owens, K. M., Kulawiec, M., Desouki, M., Vanniarajan, A., & Singh, K. K. (2011) · PLoS ONE · doi:10.1371/journal.pone.0023846 · Cited by 109
“This protein has been associated with oncogene-induced senescence [10], however, its role in tumorigenesis is not described.”
BackgroundTargeting senescence as an anticancer therapy
Bousset, L., & Gil, J. (2022) · Molecular Oncology · doi:10.1002/1878-0261.13312 · Cited by 123
Stanicka, J., Russell, E. G., Woolley, J. F., & Cotter, T. G. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.510495 · Cited by 107
Pitiyage, G. N., Slijepčević, P., Gabrani, A., Chianea, Y. G., Lim, K. P., Prime, S. S., Tilakaratne, W. M., Fortune, F., & Parkinson, E. K. (2010) · The Journal of Pathology · doi:10.1002/path.2839 · Cited by 101
Selective elimination of senescent cells by mitochondrial targeting is regulated by ANT2
Hubáčková, S., Davidová, E., Rohlenová, K., Štursa, J., Werner, L., Anděra, L., Dong, L., Terp, M. G., Hodný, Z., Ditzel, H. J., et al. (2018) · Cell Death and Differentiation · doi:10.1038/s41418-018-0118-3 · Cited by 107
“Consequently, exacerbation of these perturbations could contribute to the induction of cell death [48, 49].”
BackgroundMitochondrial dysfunction and its association with age-related disorders
Somasundaram, I., Jain, S. M., Blot‐Chabaud, M., Pathak, S., Banerjee, A., Rawat, S. J., Sharma, N. R., & Duttaroy, A. K. (2024) · Frontiers in Physiology · doi:10.3389/fphys.2024.1384966 · Cited by 137
Strategies for late phase preclinical and early clinical trials of senolytics
Wissler Gerdes, E. O., Misra, A., Netto, J. M. E., Tchkonia, T., & Kirkland, J. L. (2021) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2021.111591 · Cited by 103
Integrating the Hallmarks of Aging Throughout the Tree of Life: A Focus on Mitochondrial Dysfunction
van der Rijt, S., Molenaars, M., McIntyre, R. L., Janssens, G. E., & Houtkooper, R. H. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.594416 · Cited by 106
Oxidative Stress-Induced Cellular Senescence: Is Labile Iron the Connecting Link?
Nousis, L., Kanavaros, P., & Barbouti, A. (2023) · Antioxidants · doi:10.3390/antiox12061250 · Cited by 116
Role of Mitochondria in Retinal Pigment Epithelial Aging and Degeneration
Tong, Y., Zhang, Z., & Wang, S. (2022) · Frontiers in Aging · doi:10.3389/fragi.2022.926627 · Cited by 104
MutT Homolog 1 (MTH1) maintains multiple KRAS-driven pro-malignant pathways
Patel, A., Burton, D. G. A., Halvorsen, K., Balkan, W., Reiner, T., Perez‐Stable, C., Cohen, A., Munoz, A., Giribaldi, M. G., Singh, S., et al. (2014) · Oncogene · doi:10.1038/onc.2014.195 · Cited by 92
Metadata
- Authors
- Moiseeva, O., Bourdeau, V., Roux, A., Deschênes-Simard, X., & Ferbeyre, G.
- Affiliations
- Université de Montréal (CA)
- Département de Biochimie, Université de Montréal, C.P. 6128, Succ. Centre-Ville, Montréal, Québec H3C 3J7, Canada
- Venue
- Molecular and Cellular Biology
- Publisher
- Informa UK Limited
- Published
- 2009-08-01
- Volume
- 29
- Issue
- 16
- Pages
- 4495-4507
- ISSN
- 0270-7306 (ISSN-L)
- 1098-5549
- PMC
- PMC2725737
- OpenAlex
- W2007244362
- Semantic Scholar
- 0f205d3fb7be9572b5161598c2febdb513a25421
- Cited by
- 408
- References
- 52
- Citations by year
- 2026: 15 · 2025: 27 · 2024: 28 · 2023: 32 · 2022: 29 · 2021: 28 · 2020: 36 · 2019: 28 · 2018: 25 · 2017: 22 · 2016: 25 · 2015: 16 · 2014: 25 · 2013: 12 · 2012: 22
- FWCI
- 13.25
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- journals.asm.org/non-commercial-tdm-license (tdm)
- Locations
- Molecular and Cellular Biology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
- Keywords
- oncogene-induced senescence, mitochondrial dysfunction, oncogenic Ras, reactive oxygen species, mitochondrial DNA, oxidative DNA damage, AMPK activation, p53, Rieske iron-sulfur protein, electron transport inhibition, oxidative phosphorylation, ATP depletion, mitochondrial mass
- MeSH terms
- Adenylate Kinase, Animals, Cell Cycle, Cell Line, DNA Damage, Enzyme Activation, Humans, Mitochondria, Genes, ras, Electron Transport Complex III, Cellular Senescence, Reactive Oxygen Species, Oxidative Stress, ras Proteins, Gene Expression Profiling, Genes, Mitochondrial, Membrane Potential, Mitochondrial
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-29, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-29 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.